Long-Term Survival under Arterial Chemoembolization and Sorafenib of a Patient with Hepatocellular Carcinoma and Tumor Atrial Thrombus: A Case Report and Literature Review

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3192867 17 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Long-Term Survival under Arterial Chemoembolization and Sorafenib of a
Patient with Hepatocellular Carcinoma and Tumor Atrial Thrombus: A Case
Report and Literature Review
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Hepatocellular carcinoma (HCC) is considered to be the fourth most
frequent cause of cancer-associated death globally. HCC might be
associated, especially in advanced stages, with the formation of tumor
thrombus (TT), which can be located in the portal vein, as well as in
hepatic and/or inferior vena cava (IVC) veins. Nevertheless, the
extension of TT to the right atrium (RA) is infrequent with an
unfavorable prognosis. We present a rare case of a male patient with HCC
and IVC TT extending to the RA. The atrial thrombus was the first
manifestation of HCC diagnosed by cardiac ultrasound. So far, the
patient has undergone 4 courses of transarterial chemoembolization in
combination with systemic therapy with sorafenib, and under this
therapeutic approach long-term survival has been achieved.
Έτος δημοσίευσης:
2020
Συγγραφείς:
Mavroudis, Andreas
Cholongitas, Evangelos
Περιοδικό:
Gastrointestinal Tumors
Εκδότης:
Karger
Τόμος:
7
Αριθμός / τεύχος:
4
Σελίδες:
156-161
Λέξεις-κλειδιά:
Hepatocellular carcinoma; Right atrium tumor thrombus; Sorafenib;
Transarterial chemoembolization
Επίσημο URL (Εκδότης):
DOI:
10.1159/000509186
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.